Aeglea BioTherapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.08.21	Aeglea BioTherapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights (PR Newswire)
15.07.21	Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel (PR Newswire)
14.07.21	Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherite... (PR Newswire)
08.07.21	Aeglea BioTherapeutics Appoints Jonathan D. Alspaugh as Chief Financial Officer (PR Newswire)
24.06.21	Aeglea BioTherapeutics Doses First Patient in a Phase 1/2 Clinical Trial of AGLE-177, a Potential First-in-Class Treatment for Homocystinuria (PR Newswire)
22.06.21	Aeglea BioTherapeutics Appoints Marcio Souza to Board of Directors (PR Newswire)
08.03.21	MÄRKTE USA/Uneinheitlich - Zinsanstieg belastet Technologiewerte (Dow Jones)
08.03.21	MÄRKTE USA/Börsen starten etwas fester in die Woche (Dow Jones)
08.03.21	MÄRKTE USA/Börsen zum Start etwas leichter erwartet (Dow Jones)
31.05.20	So stuften die Analysten die Aeglea BioTherapeutics-Aktie im vergangenen Monat ein (finanzen.net)
28.04.20	Stock Alert: Aeglea BioTherapeutics Up 18% (RTTNews)
05.03.19	Ausblick: Aeglea BioTherapeutics stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
05.09.18	AGLE Falls On Analyst Downgrade, CNST On Watch, Busy Q4 Ahead For UMRX (RTTNews)
28.08.18	AFMD Soars On Genentech Deal, AKCA Slumps On Rejection, FDA Nod For TTPH (RTTNews)
08.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…) (RTTNews)
30.03.18	FOMX To Report Data In Q3, INNT Continues To Sizzle, All Eyes On GALT (RTTNews)
11.03.18	An Ear To The Pharma: 4 Stocks To Watch This Week (RTTNews)
09.03.18	FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month (RTTNews)
01.03.18	ECYT Has VISION, LPCN Up 50% In 5 Days, MYO On Watch, FDA Nod Boosts SRNE (RTTNews)
30.11.17	TXMD Giving A 2nd Try, PLX On Watch, NAOV's Shield Against Suicide Disease (RTTNews)
24.10.17	AIMT Gains As DBVT Bleeds, PETS Gets Attention, FLDM On Watch (RTTNews)
13.10.17	INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints (RTTNews)
10.10.17	BGNE Hits Record High, SYRS Awaits Catalysts, ALT To Report Data In Q4 (RTTNews)
08.09.17	NLNK Rallies On Indoximod Data, VRNA Breathes Easy, ALNY Jolted (RTTNews)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)
11.07.17	Gainers & Losers Of July 10: KMPH, DOVA, AGLE, LMAT, OCUL... (RTTNews)
07.06.17	Gainers & Losers Of June 6: VTL, EGLT, AMRI, AGLE, CRVS... (RTTNews)
25.05.17	Gainers & Losers Of May 24: PBYI, INO, NVCR, AKAO, NBIX... (RTTNews)
24.05.17	Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE... (RTTNews)
24.03.17	FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars (RTTNews)
24.05.16	EXEL Rises On Trial Data, XNPT Agrees To Be Acquired, NVO Faces FDA Panel Today (RTTNews)
07.04.16	Aeglea BioTherapeutics Prices 5 Mln IPO At $10/shr, Below Expected Range (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Aeglea BioTherapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten